A comprehensive view of Pharmaceutical Research and Manufacturers of America PhRMA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Court upholds Arkansas' 340B Drug Pricing Nondiscrimination Act against constitutional challenge by Pharmaceutical Research and Manufacturers of America; court rules the Federal Food, Drug, and Cosmetic Act does not preempt the state law
Published:
March 12, 2024
by The American Hospital Association (AHA)
|
PhRMA files lawsuit against the HHS Medicare drug price negotiation program, alleging constitutional violations; the suit follows Merck's challenge earlier this month and similar suits filed by the Chamber of Commerce and Bristol Myers Squibb
Published:
June 22, 2023
by Inside Health Policy
|
Politico reports AstraZeneca leaving US pharma lobbying group PhRMA after recent assessment of membership; AbbVie and Teva have both also recently left the lobbying group
Published:
May 16, 2023
by FiercePharma
|
Ask us about our Government & Public Policy market view